XNCR FY 2023 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$175M+6.1% YoY

Gross Profit

$175M100.0% margin

Operating Income

-$132M-75.8% margin

Net Income

-$133M-76.2% margin

EPS (Diluted)

$-2.08

Cash Flow

Operating Cash Flow

-$78M

Free Cash Flow

-$96M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$953M

Total Liabilities

$284M

Stockholders' Equity

$669M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$175M	$165M	+6.1%
Gross Profit	$175M	$165M	+6.1%
Operating Income	-$132M	-$82M	-60.5%
Net Income	-$133M	-$55M	-141.3%